
Sign up to save your podcasts
Or
Moderator: Barbara Tettenborn (St. Gallen, Switzerland)
Guest: Thomas Meinel (Bern, Switzerland)
Thomas Meinel, a clinician scientist at the Burn Stroke Research Center in Switzerland, is hosted by Barbara Tettenborn as they discuss covert cerebrovascular disease. His research, particularly on strokes in patients on anticoagulation, is explored, highlighting the frequency and clinical implications of covert cerebrovascular lesions. Meinel emphasizes the current lack of clear evidence for managing these conditions. He also shares insights into ongoing studies that aim to connect epidemiological knowledge with clinical practices, encouraging neurologists to recognize and address covert cerebrovascular disease in patient care.
Moderator: Barbara Tettenborn (St. Gallen, Switzerland)
Guest: Thomas Meinel (Bern, Switzerland)
Thomas Meinel, a clinician scientist at the Burn Stroke Research Center in Switzerland, is hosted by Barbara Tettenborn as they discuss covert cerebrovascular disease. His research, particularly on strokes in patients on anticoagulation, is explored, highlighting the frequency and clinical implications of covert cerebrovascular lesions. Meinel emphasizes the current lack of clear evidence for managing these conditions. He also shares insights into ongoing studies that aim to connect epidemiological knowledge with clinical practices, encouraging neurologists to recognize and address covert cerebrovascular disease in patient care.
4,335 Listeners
90,779 Listeners
278 Listeners
317 Listeners
35 Listeners
476 Listeners
111,466 Listeners
14 Listeners
21 Listeners
130 Listeners
10 Listeners
44 Listeners
43 Listeners
174 Listeners
74 Listeners